Xconomy’s Digital Events →
November 17, 2020 · New York
Joanne Gibbons is a senior consultant and Emily Welsch is a consultant at Halloran Consulting Group, a specialty consulting firm to life science companies focusing on clinical, regulatory and quality.
Consumers and life science startup companies alike are reacting strongly to the recent decision by the FDA to restrict the genetic testing company, 23andMe, from marketing its genetic testing service. In... Read more »
Sponsored · Whitepaper
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.